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IT IS ACCEPTED GENERALLY that peripheral vasoconstrictor responses to norepinephrine are augmented in animals or human subjects receiving corticosteroids' even though the bulk of the evidence for2-7 or against8 9 this concept has been based primarily on observations of pressor responses to norepinephrine. Augmented pressor responses to norepinephrine after treatment with steroids need not be caused by enhanced vasoconstriction alone. They could result from increased blood flow or from a combination of increased flow and increased vasoconstriction. Studies such as those showing that strips of rabbit aorta contract more forcefully in the presence of norepinephrine and corticosteroid than in the presence of norepinephrine alone'0 have been cited to support the belief that increased vasoconstriction is responsible for the augmented pressor response. In humans one study is available to show that blood flow does not increase when norepinephrine is given after treatment with steroids."1 In this case observations were made of blood flow and pressure in the skin of the digit. It seemed important to consider the possibility that corticosteroids might influence blood flow responses to norepinephrine in other vascular beds, especially in view of recent reports that glucocorticoids and mineralocorticoids increase myocardial contracility in vitro '12, 13 and that glucocorticoids increase cardiac output in humans14 and dogs.'5 The experiments to be reported herein were done to study pressure-flow responses in the human forearm to norepinephrine before and after treatment with 9-a-fluorohydrocortisone.
Methods
Eight healthy male students, 21 to 23 years old, were studied during three sessions. Session A was before administration of 9-a-fluorohydrocortisone. Session B was after 1 week of treatment with 9-ax-fluorohydrocortisone, 1 mg initially and then 0.2 mg per day. Session C took place 3 weeks after stopping treatment. Studies were carried out in a warm (82 F), darkened room. A subject was studied at a comparable time of day during each session. Venous blood samples were drawn at the start of each session, after which a polyethylene catheter was inserted into the right antecubital vein for drug infusion using a Harvard pump.
The left forearm was placed in a limb segment plethysmograph. A loose neoprene rubber sleeve attached to the plethysmograph enclosed the limb segment. Adjustable metal plates at the ends of the plethysmograph were fitted to the contour of the limb to prevent ballooning of the rubber sleeve. When water filled the plethysmograph, the sleeve was forced into loose folds against the arm and inner surface of the plates. The water surrounding the arm was at 90 F. The level of water was slightly greater than venous pressure. This reduced transmural venous pressure to a low constant value'6 so that the veins could be distended freely when venous congestion was produced by suddenly inflating a pneumatic cuff about the arm proximal to the plethysmograph. For each study, the minimum venous occlusion pressure required to produce the maximum rate of increase in arm volume was used.
Circulation, Volume XXXIV, October 1966 A pneumatic cuff distal to the plethysmograph was inflated to suprasystolic pressures during sets of observations to arrest circulation to the hand. An increase in the volume of the arm within the rubber sleeve displaced water in an open tube at the top of the plethysmograph; thus a change in arm volume could be recorded by a Statham strain gauge as a change in hydrostatic pressure. Right brachial artery pressure was measured by auscultation. Pulse rate was counted from the recording from a pulse detector taped over a digital artery. Digital pulses and blood flow rates were recorded on a Sanborn direct writing oscillograph.
After subjects achieved a stable resting state, observations were begun. Arterial pressure, forearm blood flow (an average of six flow curves per minute), and pulse were recorded for 3 minutes before and during three consecutive 4-minute intravenous infusions of norepinephrine (as the base) in ascending doses of 0.075, 0.15, and 0.30 p,g/kg/min. Averages of blood flows, blood pressures, and pulse rates from the 3-minute period before norepinephrine and from the final minute of each infusion were tabulated.
Forearm blood flow was calculated as the rate of increase in forearm volume and expressed in milliliters per minute per 100 ml of forearm. Vascular resistance was calculated as the ratio of mean arterial pressure to blood flow and expressed in arbitrary units. Mean arterial pressure was determined by adding one third of the pulse pressure to the diastolic pressure. Hematocrit was measured by the method of Wintrobe.17 Sodium and potassium were measured with a Baird flame photometer and chloride was measured with a Buchlar-Cotlove chloridometer. The data were subjected to analysis of variance. In one instance, Tukey's test was used for multiple comparisons.18
Results
Administration of fluorohydrocortisone had no significant effect on body weight, hematocrit, serum potassium or serum chloride (table 1). Serum sodium, however, was elevated significantly in session B as a result of fluorohydrocortisone administration. Mean arterial pressure, forearm blood flow, forearm vascular resistance, and pulse rate before infusion of norepinephrine did not differ statistically in the three sessions (table 1), suggesting that fluorohydrocortisone had no significant effect on these resting levels. It should be pointed out, however, that average resting forearm blood flow tended to be higher in session B. table 3 and figure 1. The decreases in blood flow were greater in session B than in session A or C ( fig. 1 ). Changes in mean arterial pressure were similar during norepinephrine infusion in all three sessions, but despite similar levels of distending pressure, increases in forearm vascular resistance were greater in session B. Decreases in pulse rate were about the same in each session. 1t co "t 't vn -t "t "t 0 t CZ m co z 0 t-co s CD x CO xo C0 *-CO ai t to to O r 't 't 't "Q n "t V Lr 7t 7 0 " I C~<~~~~~Q ln 'r°C 0t -t 't co: C C-0 5)5 N 00 00 t m~1 > 00' C .n o t dq t m n Kt t t t t n t r m .t 
Discussion
In this study, forearm vascular resistance during infusions of norepinephrine increased to greater levels after treatment with 9-a-fluorohydrocortisone. An increase in resistance implies a decrease in vascular caliber. The fact that vessel caliber decreased more against similar levels of distending pressure during norepinephrine infusions after administration of fluorohydrocortisone indicates that the constrictor response of the smooth muscle of the resistance vessels must have been augmented.
In the resting state after administration of fluorohydrocortisone but before infusion of norepinephrine, average forearm blood flow tended to be higher and forearm vascular resistance tended to be lower than in the control sessions. These observations imply that resting vascular caliber was not compromised after fluorohydrocortisone treatment, and suggest that edema probably did not occur in the walls of resistance vessels as a result of steroid therapy. Furthermore, forearm blood flow in session B, when compared to control sessions, decreased from higher average levels before norepinephrine to lower levels during infusion of norepinephrine. This serves to emphasize, even more, the noted statistical significance of decreases in forearm blood flow which occurred with norepinephrine after fluorohydrocortisone.
The doses of fluorohydrocortisone used in this study were sufficient to cause a significant increase in serum sodium without measurable change in body weight or hematocrit and without gross evidence of fluid retention. The elevated serum sodium per se probably did not contribute to the augmented vascular responsiveness to norepinephrine.
Haddy19 demonstrated that elevating serum sodium by acute administration of sodium chloride or other sodium salts decreased vascular tone and reactivity to constrictor stimuli. Increased responsiveness to norepinephrine in the present study however may have been related to sodium and potassium shifts across the cell membrane. Increases in intracellular sodium and decreases in intracellular potassium have been shown Responses to norepinephrine. (A) Session before 9-a-fluorohydrocortisone, (B) session after 1 week of treatment with 9-a-fluorohydrocortisone, and (C) session 3 weeks after stopping treatment. Each point represents the average of observations made in eight subjects during each session. The dose response regressions in session B were compared with pooled dose response regressions in sessions A and C and differences were considered significant at P < 0.05 (indicated by asterisks). The statistical analysis was done in the following manner: The regression (b) was calculated by subtracting the low-dose observation from the high-dose observation. This regression for session B (bB) was compared to corresponding regressions for sessions A and C (bA,, bc) by calculating d (d =-bA + 2bB -bc) for each subject separately. The ratio of the average d in the eight subjects to the standard error of d was used to determine the t value for the comparisons of the regressions in session B and regressions in sessions A and C.
to accompany administration of mineralocor-ticoids20-23 and infusion of vasoconstricting drugs including norepinephrine.24 27 Furthermore, the importance of sodium mobility to vascular reactivity has been demonstrated by Friedman and associates.28 They observed that, in the perfused rat tail, vascular responses to infusions of norepinephrine were abolished or restored by acute manipulations that respectively decreased or restored intracellular levels of sodium. These observations relating electrolyte shifts to vascular reactivity are consistent with Raab's1 and Bohr and associates'23 suggestion that decreases in transcellular gradients of sodium and potassium increase the responsiveness of smooth muscle to contractile stimuli. Summary Vascular responses to norepinephrine were studied in normal subjects during three sessions. The first session took place before Circulation. Volume XXXIV, October 1966 624 130 120 110 55 45 35 steroid treatment. The second session took place 1 week after daily oral administration of 9-a-fluorohydrocortisone. The third session was conducted 3 weeks after stopping treatment. Forearm blood flow decreased and forearm vascular resistance increased more during norepinephrine infusions in the session immediately after the administration of 9-a!-fluorohydrocortisone than in either control session. Increases in resistance against the same levels of blood pressure in the session after steroid treatment indicate that the responsiveness of vascular smooth muscle to norepinephrine was augmented after 1 week of treatment with 9-a-fluorohydrocortisone. The data indicate that blood flow to the forearm during norepinephrine infusion is not enhanced by administration of fluorohydrocortisone.
